Alternatives When an Authorized Medicinal Product is Not Available
The industrialization of medicinal products has permitted us to reach important results in terms of quality, efficacy, safety, and availability of drugs; however, not all the legitimate expectations of patients are met. When an authorized medicinal product is not available on the market, the physici...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-01-01
|
Series: | Medicine Access @ Point of Care |
Online Access: | https://doi.org/10.5301/maapoc.0000005 |
id |
doaj-e389190ef06141538f0a74d294c649d9 |
---|---|
record_format |
Article |
spelling |
doaj-e389190ef06141538f0a74d294c649d92020-11-25T03:02:47ZengSAGE PublishingMedicine Access @ Point of Care2399-20262017-01-01110.5301/maapoc.0000005Alternatives When an Authorized Medicinal Product is Not AvailableFrancesca Selmin0Umberto M. Musazzi1Francesco Cilurzo2Paola Minghetti3Department of Pharmaceutical Sciences, Universitè degli Studi di Milano, Milan - ItalyDepartment of Pharmaceutical Sciences, Universitè degli Studi di Milano, Milan - ItalyDepartment of Pharmaceutical Sciences, Universitè degli Studi di Milano, Milan - ItalyDepartment of Pharmaceutical Sciences, Universitè degli Studi di Milano, Milan - ItalyThe industrialization of medicinal products has permitted us to reach important results in terms of quality, efficacy, safety, and availability of drugs; however, not all the legitimate expectations of patients are met. When an authorized medicinal product is not available on the market, the physician can prescribe other pharmacological treatments in the following scenario: off-label prescriptions, extemporaneous preparations, compassionate use of medicinal products, and medicinal products authorized in foreign countries. The best solution among these alternatives should be evaluated case-by-case on the basis of good scientific evidence, expert medical judgement, and published literature, also keeping an eye on the availability, the cost, and the regulatory requirements at a national level.https://doi.org/10.5301/maapoc.0000005 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Francesca Selmin Umberto M. Musazzi Francesco Cilurzo Paola Minghetti |
spellingShingle |
Francesca Selmin Umberto M. Musazzi Francesco Cilurzo Paola Minghetti Alternatives When an Authorized Medicinal Product is Not Available Medicine Access @ Point of Care |
author_facet |
Francesca Selmin Umberto M. Musazzi Francesco Cilurzo Paola Minghetti |
author_sort |
Francesca Selmin |
title |
Alternatives When an Authorized Medicinal Product is Not
Available |
title_short |
Alternatives When an Authorized Medicinal Product is Not
Available |
title_full |
Alternatives When an Authorized Medicinal Product is Not
Available |
title_fullStr |
Alternatives When an Authorized Medicinal Product is Not
Available |
title_full_unstemmed |
Alternatives When an Authorized Medicinal Product is Not
Available |
title_sort |
alternatives when an authorized medicinal product is not
available |
publisher |
SAGE Publishing |
series |
Medicine Access @ Point of Care |
issn |
2399-2026 |
publishDate |
2017-01-01 |
description |
The industrialization of medicinal products has permitted us to reach important results in terms of quality, efficacy, safety, and availability of drugs; however, not all the legitimate expectations of patients are met. When an authorized medicinal product is not available on the market, the physician can prescribe other pharmacological treatments in the following scenario: off-label prescriptions, extemporaneous preparations, compassionate use of medicinal products, and medicinal products authorized in foreign countries. The best solution among these alternatives should be evaluated case-by-case on the basis of good scientific evidence, expert medical judgement, and published literature, also keeping an eye on the availability, the cost, and the regulatory requirements at a national level. |
url |
https://doi.org/10.5301/maapoc.0000005 |
work_keys_str_mv |
AT francescaselmin alternativeswhenanauthorizedmedicinalproductisnotavailable AT umbertommusazzi alternativeswhenanauthorizedmedicinalproductisnotavailable AT francescocilurzo alternativeswhenanauthorizedmedicinalproductisnotavailable AT paolaminghetti alternativeswhenanauthorizedmedicinalproductisnotavailable |
_version_ |
1724688477370449920 |